Is this your Brand? Log in to Hoodie!
Log in to HoodieDosecann
Data Snapshot for Mar 19, 2026
Overview
DOSECANN's sales have dropped 34.7% YoY in the <250K tier, with a 21.6% decline over the past three months. This mid-tier brand faces challenges in maintaining revenue amidst shifting market dynamics.
Categories
- Top Category: Oral
- Price Tier: Mid-Market
- States Active: 6
Top States
Dosecann Top StatesFeb 2026
Top states where Dosecann is active based on indexed sales coverage.
Trend View
Market Insights SnapshotFeb 2026
Trend narrative unavailable.
24-Month Trend

Average Price
$18.99
YoY Sales Trend
34.7%
2Y Sales Trend
81.2%
Oral leads at 75.5% but is down 29.5% YoY. Concentrates are the standout with +39.2% YoY, while Vapes and Topicals struggle significantly, with declines of 46.6% and 73.9% respectively.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 75.5% | $19.24 | 29.5% |
| Vapes | 8.7% | $26.05 | 46.6% |
| Concentrates | 7.6% | $23.1 | 39.3% |
| Topicals | 5.6% | $40.5 | 73.9% |
| Edibles | 2.5% | $6.27 | 3.9% |
DOSECANN's strongest market is Ontario at 47.8%, followed by Alberta at 31.3%. The brand is active across 6 states, showcasing significant geographic concentration.
| State | Concentrates | Edibles | Oral | Topicals | Vapes |
|---|---|---|---|---|---|
| ⊖ | ⊖ | 5 | 8 | ⊖ | |
| 25 | ⊖ | 9 | 16 | ⊖ | |
| ⊖ | ⊖ | 12 | 13 | ⊖ | |
| ⊖ | ⊖ | 19 | 20 | ⊖ | |
| ⊖ | ⊖ | 14 | 13 | ⊖ |
Want SKU-Level Buyer Signals?
Unlock purchaser contacts, SKU-level velocity, and whitespace opportunities for this brand.
Market Position
Competitive LandscapeFeb 2026
Ranked #12 in the Oral category, DOSECANN lags behind top competitor BHANG (#1) by 11 spots. The brand slipped from #11 to #12 over the past year, facing tough competition from REDECAN and ASPIRE INFUSIONS.
SKU View
Notable ProductsFeb 2026
Top products for Feb 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1 | Topicals | 18.9% |
#2 | Vapes | 34.0% |
#3 | Vapes | 17.8% |
#4 | Vapes | 75.5% |
#5 | Vapes | 224.0% |
#6 | Edibles | 41.9% |
#7 | Edibles | 150.6% |
#8 | Oral | 0.8% |
Benchmarking
Competitive Peer Set
Peer brands benchmarked against Dosecann using competitive landscape rank coverage, proximity, and momentum.